GO:0003747 | translation release factor activity | 2.20e-06 | 2.15e-02 | 9.347 | 2 | 2 | 2 |
GO:0000778 | condensed nuclear chromosome kinetochore | 6.60e-06 | 6.45e-02 | 8.762 | 2 | 2 | 3 |
GO:0000775 | chromosome, centromeric region | 3.02e-05 | 2.95e-01 | 5.574 | 3 | 6 | 41 |
GO:0008409 | 5'-3' exonuclease activity | 4.60e-05 | 4.50e-01 | 7.539 | 2 | 2 | 7 |
GO:0051382 | kinetochore assembly | 4.60e-05 | 4.50e-01 | 7.539 | 2 | 2 | 7 |
GO:0006479 | protein methylation | 1.20e-04 | 1.00e+00 | 6.887 | 2 | 2 | 11 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 4.55e-04 | 1.00e+00 | 5.954 | 2 | 2 | 21 |
GO:0035312 | 5'-3' exodeoxyribonuclease activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0016149 | translation release factor activity, codon specific | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0016300 | tRNA (uracil) methyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0008609 | alkylglycerone-phosphate synthase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0008079 | translation termination factor activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0048256 | flap endonuclease activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0007079 | mitotic chromosome movement towards spindle pole | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:2000781 | positive regulation of double-strand break repair | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0008611 | ether lipid biosynthetic process | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0005515 | protein binding | 3.33e-03 | 1.00e+00 | 0.922 | 12 | 198 | 4124 |
GO:0006415 | translational termination | 4.07e-03 | 1.00e+00 | 4.369 | 2 | 2 | 63 |
GO:0008762 | UDP-N-acetylmuramate dehydrogenase activity | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0002098 | tRNA wobble uridine modification | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0003723 | RNA binding | 5.81e-03 | 1.00e+00 | 2.983 | 3 | 22 | 247 |
GO:0097452 | GAIT complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0006449 | regulation of translational termination | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0006333 | chromatin assembly or disassembly | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0043515 | kinetochore binding | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0071156 | regulation of cell cycle arrest | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:1990023 | mitotic spindle midzone | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0030529 | ribonucleoprotein complex | 6.81e-03 | 1.00e+00 | 3.989 | 2 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 7.14e-03 | 1.00e+00 | 3.954 | 2 | 5 | 84 |
GO:0004521 | endoribonuclease activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0008610 | lipid biosynthetic process | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0090344 | negative regulation of cell aging | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0000779 | condensed chromosome, centromeric region | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0004523 | RNA-DNA hybrid ribonuclease activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0043566 | structure-specific DNA binding | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0000940 | condensed chromosome outer kinetochore | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0046578 | regulation of Ras protein signal transduction | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0007140 | male meiosis | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0000278 | mitotic cell cycle | 1.12e-02 | 1.00e+00 | 2.637 | 3 | 28 | 314 |
GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0071949 | FAD binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0030488 | tRNA methylation | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0032039 | integrator complex | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 3 | 9 |
GO:0008143 | poly(A) binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 10 |
GO:0000398 | mRNA splicing, via spliceosome | 1.60e-02 | 1.00e+00 | 3.347 | 2 | 15 | 128 |
GO:0007080 | mitotic metaphase plate congression | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 1 | 11 |
GO:0000132 | establishment of mitotic spindle orientation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 2 | 12 |
GO:0004527 | exonuclease activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 4 | 12 |
GO:0045190 | isotype switching | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0000738 | DNA catabolic process, exonucleolytic | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 1 | 13 |
GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 14 |
GO:0005782 | peroxisomal matrix | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 16 |
GO:0008380 | RNA splicing | 2.58e-02 | 1.00e+00 | 2.980 | 2 | 21 | 165 |
GO:0043022 | ribosome binding | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 17 |
GO:0006298 | mismatch repair | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 1 | 17 |
GO:0006378 | mRNA polyadenylation | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0004842 | ubiquitin-protein transferase activity | 3.00e-02 | 1.00e+00 | 2.863 | 2 | 17 | 179 |
GO:0034080 | CENP-A containing nucleosome assembly | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0071346 | cellular response to interferon-gamma | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0051321 | meiotic cell cycle | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 20 |
GO:0005720 | nuclear heterochromatin | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 20 |
GO:0016567 | protein ubiquitination | 3.28e-02 | 1.00e+00 | 2.792 | 2 | 14 | 188 |
GO:0000049 | tRNA binding | 3.48e-02 | 1.00e+00 | 4.823 | 1 | 2 | 23 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 3.77e-02 | 1.00e+00 | 4.703 | 1 | 3 | 25 |
GO:0006281 | DNA repair | 3.78e-02 | 1.00e+00 | 2.681 | 2 | 24 | 203 |
GO:0005057 | receptor signaling protein activity | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 2 | 26 |
GO:0005654 | nucleoplasm | 3.94e-02 | 1.00e+00 | 1.572 | 4 | 68 | 876 |
GO:0000737 | DNA catabolic process, endonucleolytic | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 2 | 29 |
GO:0005778 | peroxisomal membrane | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 3 | 29 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 6 | 31 |
GO:0005871 | kinesin complex | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 3 | 31 |
GO:0017148 | negative regulation of translation | 4.95e-02 | 1.00e+00 | 4.302 | 1 | 5 | 33 |
GO:0000786 | nucleosome | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 2 | 34 |
GO:0031124 | mRNA 3'-end processing | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 4 | 35 |
GO:0045860 | positive regulation of protein kinase activity | 5.54e-02 | 1.00e+00 | 4.137 | 1 | 2 | 37 |
GO:0003682 | chromatin binding | 5.58e-02 | 1.00e+00 | 2.369 | 2 | 15 | 252 |
GO:0006369 | termination of RNA polymerase II transcription | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 5 | 38 |
GO:0048511 | rhythmic process | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 5 | 38 |
GO:0003777 | microtubule motor activity | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 3 | 39 |
GO:0007018 | microtubule-based movement | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 2 | 39 |
GO:0006396 | RNA processing | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 4 | 40 |
GO:0000724 | double-strand break repair via homologous recombination | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 5 | 42 |
GO:0006406 | mRNA export from nucleus | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 7 | 44 |
GO:0001570 | vasculogenesis | 6.70e-02 | 1.00e+00 | 3.855 | 1 | 2 | 45 |
GO:0000502 | proteasome complex | 6.99e-02 | 1.00e+00 | 3.792 | 1 | 3 | 47 |
GO:0001558 | regulation of cell growth | 7.27e-02 | 1.00e+00 | 3.732 | 1 | 2 | 49 |
GO:0005777 | peroxisome | 7.42e-02 | 1.00e+00 | 3.703 | 1 | 2 | 50 |
GO:0006310 | DNA recombination | 7.42e-02 | 1.00e+00 | 3.703 | 1 | 8 | 50 |
GO:0006334 | nucleosome assembly | 7.56e-02 | 1.00e+00 | 3.674 | 1 | 4 | 51 |
GO:0055114 | oxidation-reduction process | 7.95e-02 | 1.00e+00 | 2.080 | 2 | 9 | 308 |
GO:0000776 | kinetochore | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 8 | 55 |
GO:0006338 | chromatin remodeling | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 7 | 55 |
GO:0005694 | chromosome | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 4 | 55 |
GO:0045892 | negative regulation of transcription, DNA-templated | 8.35e-02 | 1.00e+00 | 2.038 | 2 | 17 | 317 |
GO:0000785 | chromatin | 8.70e-02 | 1.00e+00 | 3.464 | 1 | 6 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 8.98e-02 | 1.00e+00 | 3.416 | 1 | 5 | 61 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 3 | 64 |
GO:0006366 | transcription from RNA polymerase II promoter | 9.47e-02 | 1.00e+00 | 1.933 | 2 | 23 | 341 |
GO:0008270 | zinc ion binding | 9.56e-02 | 1.00e+00 | 1.426 | 3 | 39 | 727 |
GO:0001889 | liver development | 1.04e-01 | 1.00e+00 | 3.197 | 1 | 4 | 71 |
GO:0030496 | midbody | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 6 | 73 |
GO:0051726 | regulation of cell cycle | 1.07e-01 | 1.00e+00 | 3.157 | 1 | 3 | 73 |
GO:0001649 | osteoblast differentiation | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 5 | 74 |
GO:0015630 | microtubule cytoskeleton | 1.09e-01 | 1.00e+00 | 3.118 | 1 | 5 | 75 |
GO:0071456 | cellular response to hypoxia | 1.11e-01 | 1.00e+00 | 3.099 | 1 | 2 | 76 |
GO:0042127 | regulation of cell proliferation | 1.16e-01 | 1.00e+00 | 3.025 | 1 | 4 | 80 |
GO:0044822 | poly(A) RNA binding | 1.19e-01 | 1.00e+00 | 1.289 | 3 | 45 | 799 |
GO:0044255 | cellular lipid metabolic process | 1.28e-01 | 1.00e+00 | 2.871 | 1 | 2 | 89 |
GO:0005506 | iron ion binding | 1.32e-01 | 1.00e+00 | 2.823 | 1 | 4 | 92 |
GO:0016032 | viral process | 1.38e-01 | 1.00e+00 | 1.605 | 2 | 30 | 428 |
GO:0000086 | G2/M transition of mitotic cell cycle | 1.39e-01 | 1.00e+00 | 2.747 | 1 | 7 | 97 |
GO:0008017 | microtubule binding | 1.39e-01 | 1.00e+00 | 2.747 | 1 | 9 | 97 |
GO:0016887 | ATPase activity | 1.43e-01 | 1.00e+00 | 2.703 | 1 | 5 | 100 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 1.53e-01 | 1.00e+00 | 1.514 | 2 | 29 | 456 |
GO:0007049 | cell cycle | 1.63e-01 | 1.00e+00 | 2.501 | 1 | 8 | 115 |
GO:0003924 | GTPase activity | 1.68e-01 | 1.00e+00 | 2.452 | 1 | 7 | 119 |
GO:0006974 | cellular response to DNA damage stimulus | 1.71e-01 | 1.00e+00 | 2.428 | 1 | 11 | 121 |
GO:0003677 | DNA binding | 1.72e-01 | 1.00e+00 | 1.044 | 3 | 52 | 947 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.76e-01 | 1.00e+00 | 2.381 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 1.82e-01 | 1.00e+00 | 2.324 | 1 | 7 | 130 |
GO:0010467 | gene expression | 1.97e-01 | 1.00e+00 | 1.283 | 2 | 49 | 535 |
GO:0044212 | transcription regulatory region DNA binding | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 13 | 143 |
GO:0005622 | intracellular | 2.01e-01 | 1.00e+00 | 2.167 | 1 | 2 | 145 |
GO:0016874 | ligase activity | 2.02e-01 | 1.00e+00 | 2.157 | 1 | 11 | 146 |
GO:0005874 | microtubule | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 10 | 163 |
GO:0016071 | mRNA metabolic process | 2.32e-01 | 1.00e+00 | 1.937 | 1 | 10 | 170 |
GO:0000166 | nucleotide binding | 2.39e-01 | 1.00e+00 | 1.887 | 1 | 13 | 176 |
GO:0006412 | translation | 2.41e-01 | 1.00e+00 | 1.871 | 1 | 12 | 178 |
GO:0008152 | metabolic process | 2.46e-01 | 1.00e+00 | 1.839 | 1 | 6 | 182 |
GO:0016070 | RNA metabolic process | 2.53e-01 | 1.00e+00 | 1.792 | 1 | 10 | 188 |
GO:0005525 | GTP binding | 2.64e-01 | 1.00e+00 | 1.724 | 1 | 12 | 197 |
GO:0035556 | intracellular signal transduction | 2.66e-01 | 1.00e+00 | 1.710 | 1 | 5 | 199 |
GO:0030154 | cell differentiation | 2.72e-01 | 1.00e+00 | 1.674 | 1 | 5 | 204 |
GO:0016020 | membrane | 2.81e-01 | 1.00e+00 | 0.694 | 3 | 56 | 1207 |
GO:0007275 | multicellular organismal development | 2.83e-01 | 1.00e+00 | 1.605 | 1 | 9 | 214 |
GO:0005730 | nucleolus | 2.85e-01 | 1.00e+00 | 0.682 | 3 | 74 | 1217 |
GO:0043231 | intracellular membrane-bounded organelle | 2.87e-01 | 1.00e+00 | 1.578 | 1 | 8 | 218 |
GO:0005829 | cytosol | 2.89e-01 | 1.00e+00 | 0.543 | 4 | 88 | 1787 |
GO:0006200 | ATP catabolic process | 2.89e-01 | 1.00e+00 | 1.572 | 1 | 13 | 219 |
GO:0019901 | protein kinase binding | 3.03e-01 | 1.00e+00 | 1.489 | 1 | 8 | 232 |
GO:0008283 | cell proliferation | 3.11e-01 | 1.00e+00 | 1.446 | 1 | 8 | 239 |
GO:0006508 | proteolysis | 3.37e-01 | 1.00e+00 | 1.302 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 3.38e-01 | 1.00e+00 | 1.297 | 1 | 11 | 265 |
GO:0043565 | sequence-specific DNA binding | 3.49e-01 | 1.00e+00 | 1.243 | 1 | 8 | 275 |
GO:0008284 | positive regulation of cell proliferation | 3.53e-01 | 1.00e+00 | 1.222 | 1 | 8 | 279 |
GO:0005634 | nucleus | 3.79e-01 | 1.00e+00 | 0.267 | 6 | 158 | 3246 |
GO:0007596 | blood coagulation | 4.12e-01 | 1.00e+00 | 0.941 | 1 | 13 | 339 |
GO:0048471 | perinuclear region of cytoplasm | 4.16e-01 | 1.00e+00 | 0.920 | 1 | 11 | 344 |
GO:0044267 | cellular protein metabolic process | 4.24e-01 | 1.00e+00 | 0.887 | 1 | 14 | 352 |
GO:0046872 | metal ion binding | 4.28e-01 | 1.00e+00 | 0.479 | 2 | 24 | 934 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.46e-01 | 1.00e+00 | 0.788 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 4.50e-01 | 1.00e+00 | 0.773 | 1 | 12 | 381 |
GO:0006915 | apoptotic process | 4.76e-01 | 1.00e+00 | 0.664 | 1 | 15 | 411 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.275 | 2 | 47 | 1076 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 6.02e-01 | 1.00e+00 | 0.162 | 1 | 22 | 582 |
GO:0007165 | signal transduction | 6.25e-01 | 1.00e+00 | 0.075 | 1 | 24 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.41e-01 | 1.00e+00 | 0.016 | 1 | 29 | 644 |
GO:0005739 | mitochondrion | 6.50e-01 | 1.00e+00 | -0.018 | 1 | 32 | 659 |
GO:0006355 | regulation of transcription, DNA-templated | 6.81e-01 | 1.00e+00 | -0.135 | 1 | 31 | 715 |
GO:0044281 | small molecule metabolic process | 7.43e-01 | 1.00e+00 | -0.375 | 1 | 35 | 844 |
GO:0005524 | ATP binding | 7.63e-01 | 1.00e+00 | -0.454 | 1 | 37 | 892 |
GO:0005737 | cytoplasm | 8.13e-01 | 1.00e+00 | -0.431 | 3 | 127 | 2633 |